New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS Novartis, 12 Sep 2014 Accessed on 16 Sep 2014 from http://www.novartis.com/newsroom/media-releases/en/2014/1855482.shtml. CommentRecommendBookmarkWatch